PMID: 16527094Mar 11, 2006Paper

Recommendations for inhaled nitric oxide treatment in the newborn

Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)
J Figueras AloyComité de Estándares de la Sociedad Española de Neonatología

Abstract

The recommendations in this document describe the current indications for inhaled nitric oxide (iNO) treatment in the newborn and clearly distinguish between those supported by scientific evidence and those for which evidence is still lacking, such as its use in preterm infants. The methodology for iNO administration, its dosage and the main secondary effects are discussed, and the reasons for lack of response to this treatment are analyzed.

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.